This week, Sage Publications announced it was retracting three studies
which found that chemical abortions pose health risks. This has
received a great deal of media attention. These studies were cited by
Judge Matthew Kacsmaryk in his April 2023 decision to suspend FDA
approval of mifepristone. Additionally, litigation over the regulation
of chemical abortion drugs continues. Professor Michael New, who holds both a Master's degree and a Ph.D. from Stanford University join Mary FioRito and Lauretta Froelich to discuss the controversy.